DE2506908A1 - Dinicotinamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel - Google Patents
Dinicotinamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittelInfo
- Publication number
- DE2506908A1 DE2506908A1 DE19752506908 DE2506908A DE2506908A1 DE 2506908 A1 DE2506908 A1 DE 2506908A1 DE 19752506908 DE19752506908 DE 19752506908 DE 2506908 A DE2506908 A DE 2506908A DE 2506908 A1 DE2506908 A1 DE 2506908A1
- Authority
- DE
- Germany
- Prior art keywords
- group
- carbon atoms
- chain
- straight
- branched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7402962A SE378815B (US07498051-20090303-C00003.png) | 1974-03-06 | 1974-03-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2506908A1 true DE2506908A1 (de) | 1975-09-18 |
Family
ID=20320427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19752506908 Pending DE2506908A1 (de) | 1974-03-06 | 1975-02-19 | Dinicotinamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
Country Status (10)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4252957A (en) * | 1978-03-09 | 1981-02-24 | Pfizer Inc. | Heterocyclylcarbonyl derivatives of urea |
-
1974
- 1974-03-06 SE SE7402962A patent/SE378815B/xx not_active IP Right Cessation
-
1975
- 1975-02-19 DE DE19752506908 patent/DE2506908A1/de active Pending
- 1975-02-24 FI FI750512A patent/FI750512A/fi not_active Application Discontinuation
- 1975-03-05 NO NO750733A patent/NO750733L/no unknown
- 1975-03-05 FR FR7506899A patent/FR2262987A1/fr not_active Withdrawn
- 1975-03-05 DK DK88575*#A patent/DK88575A/da unknown
- 1975-03-06 JP JP50027556A patent/JPS50117777A/ja active Pending
- 1975-03-06 LU LU71983A patent/LU71983A1/xx unknown
- 1975-03-06 BE BE154051A patent/BE826349A/xx unknown
- 1975-03-06 NL NL7502688A patent/NL7502688A/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4252957A (en) * | 1978-03-09 | 1981-02-24 | Pfizer Inc. | Heterocyclylcarbonyl derivatives of urea |
Also Published As
| Publication number | Publication date |
|---|---|
| DK88575A (US07498051-20090303-C00003.png) | 1975-09-07 |
| JPS50117777A (US07498051-20090303-C00003.png) | 1975-09-16 |
| LU71983A1 (US07498051-20090303-C00003.png) | 1976-02-04 |
| NO750733L (US07498051-20090303-C00003.png) | 1975-09-09 |
| NL7502688A (nl) | 1975-09-09 |
| FR2262987A1 (US07498051-20090303-C00003.png) | 1975-10-03 |
| BE826349A (fr) | 1975-09-08 |
| FI750512A (US07498051-20090303-C00003.png) | 1975-09-07 |
| SE378815B (US07498051-20090303-C00003.png) | 1975-09-15 |
| SE7402962L (US07498051-20090303-C00003.png) | 1975-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2445584C3 (de) | L- bzw. DL-2-Methyl-3- (3', 4'-dihydroxyphenyl)-alanin-ester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE3143219A1 (de) | Kristalline 1,1-dioxopenicillanoyloxymethyl-6-(d-(alpha)-amino-(alpha)-phenylacetamido)-penicillanat-p-toluol-sulfonat-hydrate, verfahren zu deren herstellung und diese enthaltende arzneimittel | |
| DE1795792A1 (de) | Die serumlipoidkonzentration vermindernde arzneimittel | |
| EP0193056B1 (de) | Kombination von Flupirtin und anticholinergisch wirkenden Spasmolytika | |
| DE2822789C2 (de) | N-Acetyl-DL-methionin-(p-acetylaminophenyl)-ester, Verfahren zu seiner Herstellung und seine Verwendung | |
| DE3751036T2 (de) | Durch Carnitin dirigierte pharmazeutische Substanzen und ihre Verwendung zur Herstellung eines Arzneimittels zur Behandlung von Muskelerkrankungen. | |
| DE68910211T2 (de) | Estramustin-ester. | |
| DE2332837A1 (de) | Amine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
| DE3212736A1 (de) | Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung | |
| DE2924691C2 (US07498051-20090303-C00003.png) | ||
| DE3009071A1 (de) | 2-isopropylaminopyrimidinhydroxyderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| DE2716402A1 (de) | 7-(2,3-dihydroxypropyl)-1,3-di-n- propylxanthin, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel | |
| EP0163984A2 (de) | Dihydropyridinkombinationspräparate und Verfahren zu ihrer Herstellung | |
| DE69023045T2 (de) | Carboxamidderivate. | |
| DE2506908A1 (de) | Dinicotinamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
| DE2322561A1 (de) | Trisubstituierte imidazole | |
| DE2605243A1 (de) | Pyrazolessigsaeurehaltiges arzneimittel | |
| DE2038628B2 (de) | N,N'-Di(carboxyalkyl)-p-phenylendiamine, deren Salze und Diäthylester, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE1906322A1 (de) | Neue alpha-Alkyl-5-hydroxytryptophanester | |
| DE2049115C3 (de) | Verwendung von Calcium-5-butylpicolinat und/oder Calcium-5-pentylpicolinat bei der Bekämpfung des Parkinsonismus mit 3-(3,4-Dihydroxyphenyl)-L-alanin (L-Dopa) | |
| DE2164988C3 (de) | 2,2-Diphenylcyclopropancarbonsäureesterderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| DE1620177B2 (de) | N-(2-Hydroxyäthyl) -piperazinocarboxymethyl-te tr acy elin, dessen pharmakologisch verwendbaren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE1618042C (US07498051-20090303-C00003.png) | ||
| DE2551591A1 (de) | 4-(4-diphenylyl)-butylamine und pharmazeutische zusammensetzungen | |
| DE1620407C (de) | 3 Hydroxy 6 oxo-N phenylathyl morphinan (eis) verbindungen und ihre Salze sowie Verfahren zu deren Her stellung |
